Table 1 Baseline characteristics of patients and control
Variables | Stroke patients (N = 138) | Control (N = 138) | Test of significant | p value |
|---|---|---|---|---|
Age (years): mean ± SD | 64.27 ± 12.36 | 64.65 ± 10.2 | 0.29a | 0.33 |
Sex | ||||
 Male | 72 (52.2%) | 60 (43.5%) | 2.09b | 0.18 |
 Females | 66 (47.8%) | 78 (56.5%) | ||
Vascular risk factors: N (%) | ||||
 Hypertension | 81 (58.7%) | 20 (14.5%) | 58.10b | 0.000* |
 Diabetes mellitus | 82 (59.4%) | 44 (31.9%) | 21.08b | 0.000* |
 Dyslipidemia | 56 (40.6%) | 18 (13%) | 26.66b | 0.000* |
 Smoking | 46 (33.3%) | 12 (8.7%) | 25.23b | 0.000* |
 Atrial fibrillation | 45 (32.6%) | 10 (7.2%) | 27.81b | 0.000* |
 Ischemic heart disease | 28 (20.3%) | 12 (8.7%) | 7.48b | 0.006* |
 Peripheral vascular disease | 30 (21.7%) | 5 (3.6%) | 20.45b | 0.000* |
 Alcohol | 8 (5.8%) | 4 (2.9%) | 1.39b | 0.37 |
 Obesity | 58 (42.0%) | 40 (28.9%) | 5.12b | 0.02* |
Laboratory findings: mean ± SD | ||||
 Calcium level (mg/dl) | 8.69 ± 0.92 | 8.73 ± 0.99 | 0.34a | 0.63 |
 Phosphorus level (mg/dl) | 3.96 ± 0.69 | 4.06 ± 0.54 | 1.34a | 0.18 |
 Vitamin D (ng/ml) | 13.47 ± 7.04 | 37.62 ± 4.4 | 34.17a | 0.000* |
 Alkaline phosphatase (μ/L) | 68.43 ± 19.6 | 66.65 ± 20.82 | 0.73a | 0.46 |